Diagnosis Glaucoma

Dr. Quigley and Dr. Kaleem continue to discuss minimally invasive glaucoma surgeries (MIGS) this week, this time focusing the surgeries that go in through the subconjunctival space, specifically the Xen and the PreserFlo, and how they compare to other glaucoma surgery options.

In this third part of the glaucoma surgery series, Dr. Quigley and Dr. Kaleem explain the Minimally Invasive Glaucoma Surgery (MIGS) procedures. They compare these procedures to those discussed in the previous two episodes, Episodes 17 and 18, and outline the risks and benefits to these particular procedures.

Dr. Quigley and Dr. Kaleem continue their discussion of glaucoma surgery options by explaining the tube shunt surgery. They compare it to the trabeculectomy, discussed in Episode 17, and talk about its risks and benefits.

Dr. Quigley and Dr. Kaleem begin their discussion of glaucoma surgical treatment options with the trabeculectomy. They explain what the procedure involves, as well as its risks and benefits. 

In this continuation of Episode 15, Dr. Quigley and Dr. Kaleem discuss how glaucoma and cataracts affect each other and surgical options to treat both problems. 

In this episode, Dr. Quigley and Dr. Kaleem discuss what cataracts are and the risk factors for developing them. They also explain options for treating cataracts and the risk and benefits of cataract surgery.

Following up on last week's episode, Dr. Quigley and Dr. Kaleem discuss laser treatments for closed angle glaucoma, as opposed to those for open angle glaucoma. They explain what the laser iridotomy is and whether or not patients who are closed angle glaucoma suspects should get it.
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:

-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: [email protected]

-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: [email protected]

To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/

Thank you for advancing
glaucoma research! We are so grateful for your support.

In this episode, Dr. Quigley and Dr. Kaleem discuss another type of treatment--the laser trabeculoplasty. They explain what it is, how it works, and what to expect as a patient.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:

-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: [email protected]

-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: [email protected]

To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/

Thank you for advancing
glaucoma research! We are so grateful for your support.

In part two of this two episode series, Dr. Quigley and Dr. Kaleem answer many of the most common questions about glaucoma medications, including cost and methods of storing, taking, and remembering to take eye drops. 
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:

-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: [email protected]

-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: [email protected]

To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/

Thank you for advancing
glaucoma research! We are so grateful for your support.

In part one of this two episode series, Dr. Quigley and Dr. Kaleem describe some of the most commonly used medications to treat glaucoma and ocular hypertension, including their mechanisms and their side effects. Stay tuned for part two!
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:

-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: [email protected]

-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: [email protected]

To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/

Thank you for advancing
glaucoma research! We are so grateful for your support.